Every BriefAsia story tagged Pharmaceuticals, newest first.
Nabota now operates across seven Middle Eastern markets, marking the widest footprint among South Korean toxin brands in the region
The Swiss pharmaceutical giant and Asia's largest healthcare distributor have renewed their collaboration, securing supply continuity for oncology and rare disease treatments across the archipelago.
South Korean pharmaceutical company signs distribution deal with Eurofarma as CEO joins presidential trade delegation for first time
HLB Pep's Drug Master File registration marks a strategic step in the company's bid to supply critical-care ingredients to American pharmaceutical manufacturers
Agreements span vaccine production, medical devices, and API manufacturing as Islamabad moves to reduce import dependence and build domestic capacity
Washington's proposal to impose up to 200 percent tariffs on imported pharmaceuticals threatens to disrupt supply chains across Asia, even in markets with minimal direct exposure.
Two-year ultimatum demands pharmaceutical production shift to U.S. soil or face import duties that could double by 2028
The South Korean biotech giant aims to expand into obesity and diabetes drug production through the all-cash acquisition of PolyPeptide
City targets WHO recognition for its Centre for Medical Products Regulation as it pivots from reliance on foreign approvals to primary evaluation hub
The Mumbai-based drugmaker recorded positive returns across multiple timeframes, with trading volumes nearing recent averages amid sustained investor interest in Indian pharmaceutical equities.
